Fosun subsidiary Wanbang licenses Sirona's SGLT2 inhibitor

 
• By Gemma Collier
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapy Areas